Literature DB >> 1716003

The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team.

J E Sanders1.   

Abstract

These data demonstrate that endocrine function abnormalities influencing subsequent growth and development in children after marrow transplantation rarely occur after preparation with CY alone. However, after administration of regimens containing TBI, multiple endocrine function abnormalities can occur. Although longer follow-up is needed, it appears that the addition of BU to CY does not result in thyroid function or growth abnormalities. Pubertal development and gonadal function, however, may be adversely influenced by BU and patients may require supplementation with appropriate gonadal hormones.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716003

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  20 in total

Review 1.  Endocrine sequelae of cancer therapy in childhood.

Authors:  F B Diamond; B B Bercu
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

Review 2.  Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.

Authors:  Smita Bhatia
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

3.  Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.

Authors:  Partow Kebriaei; Roland Bassett; Genevieve Lyons; Ben Valdez; Celina Ledesma; Gabriela Rondon; Betul Oran; Stefan Ciurea; Amin Alousi; Uday Popat; Krina Patel; Sairah Ahmed; Amanda Olson; Qaiser Bashir; Nina Shah; Roy Jones; David Marin; Katayoun Rezvani; Yago Nieto; Issa Khouri; Muzaffar Qazilbash; Chitra Hosing; Elizabeth Shpall; Richard E Champlin; Borje S Andersson
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-02       Impact factor: 5.742

Review 4.  Late effects of total body irradiation.

Authors:  A D Leiper
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

Review 5.  How to treat relapsed acute lymphoblastic leukemia: transplant vs. conventional chemotherapy.

Authors:  Sandeep Jain; Gauri Kapoor
Journal:  Indian J Pediatr       Date:  2013-04-30       Impact factor: 1.967

Review 6.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

7.  Prolonged intrathecal chemotherapy replacing cranial irradiation in high-risk acute lymphatic leukaemia: long-term follow up with cerebral computed tomography scans and endocrinological studies.

Authors:  H Hasle; J Helgestad; J K Christensen; B B Jacobsen; J Kamper
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

8.  Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia.

Authors:  Yun-Hee Lee; Ji-Yoon Kim; Byung-Ock Choi; Mi-Ryeong Ryu; Su-Mi Chung
Journal:  Radiat Oncol J       Date:  2012-12-31

Review 9.  Preservation of fertility in children treated for cancer.

Authors:  W H B Wallace; A B Thomson
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

10.  Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.

Authors:  M Horstmann; M Stockschläder; W Krüger; M Hoffknecht; R Betker; H Kabisch; A Zander
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.